News Focus
News Focus
Followers 71
Posts 4827
Boards Moderated 0
Alias Born 01/24/2004

Re: north40000 post# 305581

Wednesday, 07/26/2017 10:18:52 AM

Wednesday, July 26, 2017 10:18:52 AM

Post# of 347009
N40K, here's the Nov’15 SITC Conf. you attended (Natl.Harbor MD)

11-9-15 SITC'15: New Bavi+Checkpoint Inhibitors preclin. data (DUKE's Herbert K. Lyerly + PPHM + UTSW)
...Also, collab. with Dr. Bernard Fox (Immunotherapist/Earle A. Chiles Res.Inst.) on new Immuno-Profiling Clinical Test (Opal 6-plex quantitative IF Assay), PPHM roundtable with Raymond Birge (Rutgers), Douglas Graham (Emory), Dmitry Gabrilovich (Wistar), Rolf Brekken (UTSW), Maria Karasarides (AstraZeneca)
”Combining Bavi w/anti-PD-1 significantly enhanced O/S…
significantly increases CD45+, CD8+ and CD3+ T-cells…
led a prolonged anti-tumor immune response which
protected the animals against a re-challenge w/same tumor.”

SEE:
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=118351795

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y